Cost-utility analysis of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in combination with gemcitabine in metastatic pancreatic cancer in Spain: Results of the PANCOSTABRAX study

dc.contributor.author	López López, Rafael
dc.date.accessioned	2017-06-07T07:34:44Z
dc.date.available	2017-06-07T07:34:44Z
dc.date.issued	2015
dc.identifier.issn	1473-7167
dc.identifier.uri	http://hdl.handle.net/20.500.11940/8161
dc.language.iso	eng
dc.title	Cost-utility analysis of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in combination with gemcitabine in metastatic pancreatic cancer in Spain: Results of the PANCOSTABRAX study
dc.type	Artigo	es
dc.authorsophos	Carrato, A.
dc.authorsophos	García, P.
dc.authorsophos	Lopez, R.
dc.authorsophos	Macarulla, T.
dc.authorsophos	Rivera, F.
dc.authorsophos	Sastre, J.
dc.authorsophos	Gostkorzewicz, J.
dc.authorsophos	Benedit, P.
dc.authorsophos	Perez-Alcántara, F.
dc.identifier.doi	10.1586/14737167.2015.1047349
dc.identifier.isi	358154000005
dc.identifier.pmid	25991037
dc.identifier.sophos	19503
dc.issue.number	4
dc.journal.title	Expert review of pharmacoeconomics & outcomes research
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago - Complexo Hospitalario Universitario de Santiago::Oncoloxía médica
dc.page.initial	579
dc.page.final	589
dc.rights.accessRights	openAccess
dc.typesophos	Artículo Original
dc.volume.number	15

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.